{
    "clinical_study": {
        "@rank": "43700", 
        "acronym": "KRIBS", 
        "arm_group": [
            {
                "arm_group_label": "Diet A i.e. Low FODMAP diet", 
                "arm_group_type": "Experimental", 
                "description": "The patients are thoroughly informed verbally and in writing how to eat according to the low FODMAP diet. The diet imply restrictions in carbohydrate intake and the patients need to follow a list with yes/no-foods for 4 weeks."
            }, 
            {
                "arm_group_label": "Diet B, i.e. Traditional IBS diet", 
                "arm_group_type": "Experimental", 
                "description": "The patients are thoroughly informed verbally and in writing how to eat according to traditional IBS dietary advices. The diet imply adapting to regular dietary habit with meals 6 times a day, no to big meals, to chew food thoroughly, to peel fruits and vegetables, no carbonated beverages, no chewing gum, no soft drinks, no sugar-free candies, or cookies. Reduce spicy foods, coffee, alcohol, onion, pulses, and fatty foods. Keep strictly to the dietary advice for 4 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to to assess if the new diet with a low-FODMAP(Fermented\n      Oligo-, Di-, Monosaccharides And Polyols) -content yields a milder symptom picture in IBS\n      patients compared to traditionally dietary advice in IBS. The study also aim to investigate\n      patients compliance to either dietary advices. Further, the investigators aim to find out if\n      IBS patients with different symptoms are alleviated in different ways, to be able to\n      individualize the dietary advices to result in a more optimal symptom relief in each patient\n      in the future."
        }, 
        "brief_title": "Traditional Dietary Advice Versus a Low FODMAP Diet Intake in IBS Patients", 
        "condition": "Irritable Bowel Syndrome", 
        "condition_browse": {
            "mesh_term": "Irritable Bowel Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  IBS diagnosis\n\n          -  Adult (over 18 years)\n\n          -  Be able to read/understand/write swedish\n\n        Exclusion Criteria:\n\n          -  Severe heart failure\n\n          -  Severe liver disease\n\n          -  Severe neurologic disease\n\n          -  Severe psychological disease\n\n          -  Severe gastrointestinal disease (i.e. celiac disease, IBD (inflammatory bowel\n             disease) e.g.)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02107625", 
            "org_study_id": "KRIBS1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Diet A i.e. Low FODMAP diet", 
                "intervention_name": "Diet A i.e. Low FODMAP diet", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Diet B, i.e. Traditional IBS diet", 
                "intervention_name": "Diet B, i.e. Traditional IBS diet", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Defecation", 
            "Abdominal pain"
        ], 
        "lastchanged_date": "April 7, 2014", 
        "number_of_arms": "2", 
        "official_title": "A Multi-centre, Randomized, Single-blind, Comparative Trial: Traditional Dietary Advice Versus a Low FODMAP Diet Intake in IBS Patients", 
        "overall_official": {
            "affiliation": "Sahlgrenska University Hospital, Sweden", 
            "last_name": "Hans T\u00f6rnblom, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "IBS-SSS i.e. the IBS Severity Scoring System. To assess the possible change of severity of IBS symptoms. The overall IBS score is calculated ranging from 0 to 500. A higher score implicates more severe symptom.", 
            "measure": "Symptom alleviation through the questionnaire IBS-SSS", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02107625"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sahlgrenska University Hospital, Sweden", 
            "investigator_full_name": "Hans T\u00f6rnblom", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "G\u00f6teborg University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Karolinska Institutet", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Aleris Specialistv\u00e5rd Sabbatsberg", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "G\u00f6teborg University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}